{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "COVID-19",
      "SARS-CoV-2",
      "biomarker discovery",
      "drug discovery",
      "host response",
      "mass spectrometry",
      "protein\u2212protein interactions",
      "proteomics",
      "structural proteomics",
      "virus\u2212host interactions"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "33464917",
  "DateCompleted": {
    "Year": "2021",
    "Month": "02",
    "Day": "22"
  },
  "DateRevised": {
    "Year": "2023",
    "Month": "12",
    "Day": "14"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2021",
        "Month": "01",
        "Day": "19"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1021/acs.jproteome.0c00764"
    ],
    "Journal": {
      "ISSN": "1535-3907",
      "JournalIssue": {
        "Volume": "20",
        "Issue": "2",
        "PubDate": {
          "Year": "2021",
          "Month": "Feb",
          "Day": "05"
        }
      },
      "Title": "Journal of proteome research",
      "ISOAbbreviation": "J Proteome Res"
    },
    "ArticleTitle": "Proteomic Approaches to Study SARS-CoV-2 Biology and COVID-19 Pathology.",
    "Pagination": {
      "StartPage": "1133",
      "EndPage": "1152",
      "MedlinePgn": "1133-1152"
    },
    "Abstract": {
      "AbstractText": [
        "The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), was declared a pandemic infection in March 2020. As of December 2020, two COVID-19 vaccines have been authorized for emergency use by the U.S. Food and Drug Administration, but there are no effective drugs to treat COVID-19, and pandemic mitigation efforts like physical distancing have had acute social and economic consequences. In this perspective, we discuss how the proteomic research community can leverage technologies and expertise to address the pandemic by investigating four key areas of study in SARS-CoV-2 biology. Specifically, we discuss how (1) mass spectrometry-based structural techniques can overcome limitations and complement traditional structural approaches to inform the dynamic structure of SARS-CoV-2 proteins, complexes, and virions; (2) virus-host protein-protein interaction mapping can identify the cellular machinery required for SARS-CoV-2 replication; (3) global protein abundance and post-translational modification profiling can characterize signaling pathways that are rewired during infection; and (4) proteomic technologies can aid in biomarker identification, diagnostics, and drug development in order to monitor COVID-19 pathology and investigate treatment strategies. Systems-level high-throughput capabilities of proteomic technologies can yield important insights into SARS-CoV-2 biology that are urgently needed during the pandemic, and more broadly, can inform coronavirus virology and host biology."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "QBI COVID-19 Research Group (QCRG), San Francisco, California 94158, United States."
          },
          {
            "Identifier": [],
            "Affiliation": "Quantitative Biosciences Institute (QBI), University of California, San Francisco, San Francisco, California 94158, United States."
          },
          {
            "Identifier": [],
            "Affiliation": "J. David Gladstone Institutes, San Francisco, California 94158, United States."
          },
          {
            "Identifier": [],
            "Affiliation": "Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, California 94158, United States."
          }
        ],
        "LastName": "Haas",
        "ForeName": "Paige",
        "Initials": "P"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "QBI COVID-19 Research Group (QCRG), San Francisco, California 94158, United States."
          },
          {
            "Identifier": [],
            "Affiliation": "Quantitative Biosciences Institute (QBI), University of California, San Francisco, San Francisco, California 94158, United States."
          },
          {
            "Identifier": [],
            "Affiliation": "J. David Gladstone Institutes, San Francisco, California 94158, United States."
          },
          {
            "Identifier": [],
            "Affiliation": "Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, California 94158, United States."
          }
        ],
        "LastName": "Muralidharan",
        "ForeName": "Monita",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "QBI COVID-19 Research Group (QCRG), San Francisco, California 94158, United States."
          },
          {
            "Identifier": [],
            "Affiliation": "Quantitative Biosciences Institute (QBI), University of California, San Francisco, San Francisco, California 94158, United States."
          },
          {
            "Identifier": [],
            "Affiliation": "J. David Gladstone Institutes, San Francisco, California 94158, United States."
          },
          {
            "Identifier": [],
            "Affiliation": "Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, California 94158, United States."
          },
          {
            "Identifier": [],
            "Affiliation": "Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York 10029, United States."
          }
        ],
        "LastName": "Krogan",
        "ForeName": "Nevan J",
        "Initials": "NJ"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "QBI COVID-19 Research Group (QCRG), San Francisco, California 94158, United States."
          },
          {
            "Identifier": [],
            "Affiliation": "Quantitative Biosciences Institute (QBI), University of California, San Francisco, San Francisco, California 94158, United States."
          },
          {
            "Identifier": [],
            "Affiliation": "J. David Gladstone Institutes, San Francisco, California 94158, United States."
          },
          {
            "Identifier": [],
            "Affiliation": "Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, California 94158, United States."
          }
        ],
        "LastName": "Kaake",
        "ForeName": "Robyn M",
        "Initials": "RM"
      },
      {
        "Identifier": [
          "0000-0002-0896-5910"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "QBI COVID-19 Research Group (QCRG), San Francisco, California 94158, United States."
          },
          {
            "Identifier": [],
            "Affiliation": "Quantitative Biosciences Institute (QBI), University of California, San Francisco, San Francisco, California 94158, United States."
          },
          {
            "Identifier": [],
            "Affiliation": "J. David Gladstone Institutes, San Francisco, California 94158, United States."
          },
          {
            "Identifier": [],
            "Affiliation": "Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, California 94158, United States."
          }
        ],
        "LastName": "H\u00fcttenhain",
        "ForeName": "Ruth",
        "Initials": "R"
      }
    ],
    "GrantList": [
      {
        "GrantID": "T32 GM007810",
        "Acronym": "GM",
        "Agency": "NIGMS NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "R01 AI120694",
        "Acronym": "AI",
        "Agency": "NIAID NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "U19 AI135990",
        "Acronym": "AI",
        "Agency": "NIAID NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "R01 AI122747",
        "Acronym": "AI",
        "Agency": "NIAID NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "U19 AI135972",
        "Acronym": "AI",
        "Agency": "NIAID NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "P50 AI150476",
        "Acronym": "AI",
        "Agency": "NIAID NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "R01 AI143292",
        "Acronym": "AI",
        "Agency": "NIAID NIH HHS",
        "Country": "United States"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, N.I.H., Extramural",
      "Research Support, Non-U.S. Gov't"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "J Proteome Res",
    "NlmUniqueID": "101128775",
    "ISSNLinking": "1535-3893"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Proteome"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Viral Proteins"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "epidemiology",
        "prevention & control",
        "virology"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Host-Pathogen Interactions"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "Mass Spectrometry"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Pandemics"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Protein Interaction Maps"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Protein Processing, Post-Translational"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Proteome"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "Proteomics"
    },
    {
      "QualifierName": [
        "metabolism",
        "physiology"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Viral Proteins"
    }
  ]
}